376 related articles for article (PubMed ID: 15185297)
1. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
Schoemaker MH; Conde de la Rosa L; Buist-Homan M; Vrenken TE; Havinga R; Poelstra K; Haisma HJ; Jansen PL; Moshage H
Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297
[TBL] [Abstract][Full Text] [Related]
2. Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes.
Hirano F; Haneda M; Makino I
J Gastroenterol Hepatol; 2006 Dec; 21(12):1807-13. PubMed ID: 17074018
[TBL] [Abstract][Full Text] [Related]
3. The effect of ursodeoxycholic acid on glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes.
Utanohara S; Tsuji M; Momma S; Morio Y; Oguchi K
Toxicology; 2005 Oct; 214(1-2):77-86. PubMed ID: 16023280
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
[TBL] [Abstract][Full Text] [Related]
5. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
Dent P; Fang Y; Gupta S; Studer E; Mitchell C; Spiegel S; Hylemon PB
Hepatology; 2005 Dec; 42(6):1291-9. PubMed ID: 16317705
[TBL] [Abstract][Full Text] [Related]
6. Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition.
Wang L; Piguet AC; Schmidt K; Tordjmann T; Dufour JF
Hepatology; 2005 Jun; 41(6):1241-51. PubMed ID: 15861431
[TBL] [Abstract][Full Text] [Related]
7. The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons.
Castro RE; Solá S; Ramalho RM; Steer CJ; Rodrigues CM
J Pharmacol Exp Ther; 2004 Nov; 311(2):845-52. PubMed ID: 15190125
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide 3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes.
Webster CR; Anwer MS
Hepatology; 2001 Mar; 33(3):608-15. PubMed ID: 11230741
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bile acid-induced apoptosis by betaine in rat liver.
Graf D; Kurz AK; Reinehr R; Fischer R; Kircheis G; Häussinger D
Hepatology; 2002 Oct; 36(4 Pt 1):829-39. PubMed ID: 12297830
[TBL] [Abstract][Full Text] [Related]
10. Pregnane X receptor activation protects rat hepatocytes against deoxycholic acid-induced apoptosis.
Zucchini-Pascal N; de Sousa G; Pizzol J; Rahmani R
Liver Int; 2010 Feb; 30(2):284-97. PubMed ID: 19737350
[TBL] [Abstract][Full Text] [Related]
11. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
12. [Effects of bile acid preparations on DNA biosynthesis, apoptosis, and necrosis in hepatocytes in vitro].
Danchenko EO
Vopr Med Khim; 2001; 47(2):236-42. PubMed ID: 11450444
[TBL] [Abstract][Full Text] [Related]
13. Involvement of endoplasmic reticulum in glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes.
Tsuchiya S; Tsuji M; Morio Y; Oguchi K
Toxicol Lett; 2006 Oct; 166(2):140-9. PubMed ID: 16860497
[TBL] [Abstract][Full Text] [Related]
14. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation.
Schoemaker MH; Gommans WM; Conde de la Rosa L; Homan M; Klok P; Trautwein C; van Goor H; Poelstra K; Haisma HJ; Jansen PL; Moshage H
J Hepatol; 2003 Aug; 39(2):153-61. PubMed ID: 12873810
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
Castro RE; Amaral JD; Solá S; Kren BT; Steer CJ; Rodrigues CM
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
[TBL] [Abstract][Full Text] [Related]
17. Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes.
Danchenko E; Petermann H; Chirkin A; Dargel R
Exp Toxicol Pathol; 2001 Jun; 53(2-3):227-33. PubMed ID: 11484843
[TBL] [Abstract][Full Text] [Related]
18. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
[TBL] [Abstract][Full Text] [Related]
19. Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.
Rust C; Bauchmuller K; Bernt C; Vennegeerts T; Fickert P; Fuchsbichler A; Beuers U
Gut; 2006 May; 55(5):719-27. PubMed ID: 16322111
[TBL] [Abstract][Full Text] [Related]
20. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D
Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
